Clinical Trial Update: A Trial of TD0019 in Treatment of Cervical Scapulohumeral Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial of TD0019 for cervical scapulohumeral syndrome has completed, with the study status indicated as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Scapulohumeral Syndrome

Drugs mentioned

• TD0019

Snippet

Sponsor: Sao Thai Duong Joint Stock Company | Conditions: Syndrome Pain | Phase 2 | Status: COMPLETED